Skip to Content

E 5156 (PAPAVERINE 150 MG)

Pill imprint E 5156 has been identified as Papaverine hydrochloride 150 MG.

Papaverine is used in the treatment of vasospasm and belongs to the drug class peripheral vasodilators. FDA has not classified the drug for risk during pregnancy. Papaverine 150 MG is not subject to the Controlled Substances Act.

See also related documents.

Papaverine hydrochloride 150 MG E 5156
Papaverine hydrochloride
E 5156
150 MG
Prescription only
Drug Class:
Peripheral vasodilators
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.